Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Clinical trials of new drugs for Alzheimer disease
Li-Kai Huang, Shu-Ping Chao, Chaur‐Jong Hu
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 587
G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 419
Circadian rhythm as a therapeutic target
Wei Ruan, Xiaoyi Yuan, Holger K. Eltzschig
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 287-307
Open Access | Times Cited: 293
The neuropeptidergic connectome of C. elegans
Lidia Ripoll-Sánchez, Jan Watteyne, HaoSheng Sun, et al.
Neuron (2023) Vol. 111, Iss. 22, pp. 3570-3589.e5
Open Access | Times Cited: 86
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
The Accuracy, Night-to-Night Variability, and Stability of Frontopolar Sleep Electroencephalography Biomarkers
Daniel J. Levendowski, Luigi Ferini‐Strambi, Charlene E. Gamaldo, et al.
Journal of Clinical Sleep Medicine (2017) Vol. 13, Iss. 06, pp. 791-803
Open Access | Times Cited: 123
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan, Cédric Vaillant, Isabelle Zenklusen, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1063-1078
Closed Access | Times Cited: 70
An update on the novel and approved drugs for Alzheimer disease
Hassan A. Alhazmi, Mohammed Albratty
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 12, pp. 1755-1764
Open Access | Times Cited: 65
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
Angela Glen, Roland W. Bürli, David G. Livermore, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 100, pp. 129629-129629
Open Access | Times Cited: 8
Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse models
Simon J. Guillot, Christina Lang, Marie Simonot, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 783
Closed Access | Times Cited: 1
The neuropeptide landscape of human prefrontal cortex
Wen Zhong, Swapnali Barde, Nicholas Mitsios, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 33
Open Access | Times Cited: 36
Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems
Gary B. Kaplan, Gabrielle A. Lakis, Hryhoriy Zhoba
Brain Research Bulletin (2022) Vol. 186, pp. 106-122
Closed Access | Times Cited: 32
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Emerging and upcoming therapies in insomnia
W.-H. Kim, Ho-Sook Kim
Translational and Clinical Pharmacology (2024) Vol. 32, Iss. 1, pp. 1-1
Open Access | Times Cited: 6
Sleep, chronic pain, and opioid risk for apnea
Serguei Marshansky, Pierre Mayer, Dorrie Rizzo, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 87, pp. 234-244
Closed Access | Times Cited: 60
Differential Roles of Each Orexin Receptor Signaling in Obesity
Miyo Kakizaki, Yousuke Tsuneoka, Kenkichi Takase, et al.
iScience (2019) Vol. 20, pp. 1-13
Open Access | Times Cited: 46
Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder
Robert Suchting, Jin H. Yoon, Guadalupe G. San Miguel, et al.
Brain Research (2019) Vol. 1731, pp. 146359-146359
Closed Access | Times Cited: 45
Molecular mechanism of the wake-promoting agent TAK-925
Jie Yin, Yanyong Kang, Aaron P. McGrath, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
The Black Book of Psychotropic Dosing and Monitoring.
Charles DeBattista, Alan F. Schatzberg
PubMed (2024) Vol. 54, Iss. 3, pp. 8-59
Closed Access | Times Cited: 5
Orexins and primary headaches: an overview of the neurobiology and clinical impact
Emily C. Stanyer, Jan Hoffmann, Philip R. Holland
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 5, pp. 487-496
Open Access | Times Cited: 5
Cholecystokinin in the central and peripheral nervous system
Tomas Hökfelt, Swapnali Barde, Wen Zhong, et al.
Elsevier eBooks (2025), pp. 101-160
Closed Access
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Page 1 - Next Page

Scroll to top